Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 6/20 | 0.35 |
| ▸ | TMPRSS6 | Q8IU80 | 4/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.34 |
| ▸ | STAT3 | P40763 | 2/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.32 |
| ▸ | CDC25A | P30304 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8216517 | 0.85 | CA12 (0.30) | CA12CA1CA2CA9CA14 | |
| SCHEMBL7708207 | 0.82 | GPR3 (0.34) | CA1CA2CA9 | |
| SCHEMBL2072597 | 0.81 | CA1 (0.41) | CA12CA1CA2CA9CA14 | |
| SCHEMBL13131074 | 0.80 | TDP1 (0.47) | CA12CA1CA2CA9CA14 | |
| SCHEMBL7702806 | 0.80 | HSD11B1 (0.38) | CA1CA2ALDH1A1TDP1 | |
| SCHEMBL7702718 | 0.80 | GPR3 (0.35) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL7708749 | 0.80 | GPR3 (0.35) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL7708214 | 0.77 | PSEN1 (0.44) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL7711392 | 0.75 | MMP13 (0.33) | ALDH1A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL406729 | 0.74 | TSHR (0.49) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7901867-B2 | Sulphonium salt initiators | BASF SE (DE) | 2011-03-08 | — | — | US | disclosed |
| EP-1902019-B1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2010-07-07 | — | — | EP | disclosed |
| US-20090208872-A1 | Sulphonium Salt Initiators | BASF SE (DE) | 2009-08-20 | — | — | US | disclosed |
| EP-1902019-A1 | SULPHONIUM SALT INITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2008-03-26 | — | — | EP | disclosed |
| WO-2007003507-A1 | SULPHONIUM SALT INITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2007-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090208872-A1 | Sulphonium Salt Initiators | OR10J3, OXSR1, ARSA | CA12 2119/4885CA1 579/4885CA2 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.